ADX-2191 was designated as an orphan medicinal product by the European Commission for the treatment of retinal detachment, according to a press release from Aldeyra Therapeutics.
We’re sorry, but an unexpected error has occurred.
Please refresh your browser and try again. If this error persists, please contact ITSupport@wyanokegroup.com for assistance.
Would you like to receive email reminders to complete your saved activities from Healio CME?
Activity saved! You'll receive reminders to complete your saved activities from Healio CME.
